Original Research
Use of Integrative Treatment Methods by Individuals With COVID-19

https://doi.org/10.1016/j.nurpra.2022.01.004Get rights and content

Highlights

  • •

    Individuals who had COVID-19 reported greater use of vitamin C and herbs.

  • •

    The suggestions of social media, families, and friends were influential in the use of integrative therapy.

  • •

    Patients with COVID-19 felt safer when using integrative treatment.

Abstract

This study was conducted to examine the use of integrative treatment methods by individuals with COVID-19 using Pender’s health promotion model. During the analysis of the themes, we observed that individuals’ decisions to start integrative treatment were affected by uncertainty related to COVID-19, desire to recover and strengthen immunity, and thinking that there would be permanent damage due to the disease. Integrative treatment methods were frequently used by individuals who had COVID-19, and these methods were primarily based on non–evidence-based information sources and not disclosed to health care professionals.

Keywords

COVID-19
health promotion model
integrative treatment
patient experience
qualitative study

Cited by (0)

Nurhan Doğan, PhD, RN is an Assistant Professor, Department of Internal Diseases Nursing, Amasya University Faculty of Health Sciences, Amasya, Turkey and can be contacted at [email protected].

Gamze Fışkın, PhD, RN is an Assistant Professor, Department of Midwifery, Amasya University Faculty of Health Sciences, Amasya, Turkey.

In compliance with standard ethical guidelines, the author reports no relationships with business or industry that would pose a conflict of interest.

Author Contributions: Idea/concept, design, consulting/supervision, literature review, and manuscript writing: ND; data collection and/or processing, analysis and/or interpretation, and critical review: ND, GF.

Data Availability: The data generated and/or analyzed during the current study are not publicly available, but data may be provided by the corresponding author upon reasonable request.

Trial registration number: NCT05089578

View Abstract
© 2022 Elsevier Inc. All rights reserved.